v3.19.2

Statement of Cash Flows - USD ($)	12 Months Ended
Statement of Cash Flows - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Details
NET LOSS	$ (837,760)	$ (1,071,348)
Change in Debt discount	86,925	84,688
Financing fees, Shares issued and note penalties	136,588	251,916
Shares issued for consulting	42,590	289
Change in Accounts Receivable	0	1,000
Change in Derivative Liability	412,705	325,407
Increase in accounts payable and accrued liabilities	104,123	204,090
Increase in accounts payable and accrued liabilities - related party	21,613	8,273
Net Cash Used in Operating Activities	(33,081)	(195,685)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds issuance of Preferred stock	15,000	0
Proceeds (payments) from notes payable	18,000	169,000
Increase (Decrease) in Cash	(81)	(26,685)
Cash and Cash Equivalents, at Carrying Value, Beginning Balance	82	26,767
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 1	$ 82

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

MJ BIOTECH, INC. 10-K